Neutrophil and basophil counts signal fibrosis risk in hypersensitivity pneumonitis :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Blood biomarkers linked to fibrotic lung changes in hypersensitivity pneumonitis

Hypersensitivity pneumonitis Hypersensitivity pneumonitis
Hypersensitivity pneumonitis Hypersensitivity pneumonitis

What's new?

Neutrophil and basophil counts significantly correlate with fibrotic HRCT patterns and bird-related antigen exposure in hypersensitivity pneumonitis.

A new real-world study delivers compelling insights into hypersensitivity pneumonitis (HP), revealing that simple blood biomarkers—neutrophil and basophil counts—may help identify fibrotic lung changes and antigen exposure patterns when combined with high-resolution computed tomography (HRCT).

HP, a complex immune-mediated interstitial lung disease, is driven by repeated inhalation of environmental antigens, often triggering chronic inflammation and irreversible pulmonary fibrosis. Despite advances, early diagnosis and disease phenotyping remain challenging. In this retrospective cross-sectional analysis, researchers evaluated 100 patients diagnosed with HP, integrating clinical data, pulmonary function testing, radiologic imaging, and hematologic parameters.

The study population had a mean age of 63 ± 14 years, with equal gender distribution. Antigen exposure was identified in 65% of patients, with a striking 86.4% linked to bird-related sources—reinforcing birds and bird products as dominant triggers in HP.

HRCT Reveals High Burden of Fibrotic Disease

HRCT imaging portrayed classic interstitial lung disease patterns:

  • Reticulation: 87%
  • Ground-glass opacities: 84.7%
  • Centrilobular nodules: 75%

Notably, 48% of patients exhibited fibrotic features, highlighting a substantial burden of fibrotic HP—a form linked with worse outcomes. Surgical lung biopsy was needed in 29% of cases, underscoring persistent diagnostic complexity.

Treatment Trends Reflect Real-World Practice

Glucocorticoids remained the primary therapy, used in 77% of patients, while antifibrotics were prescribed in 20%, particularly in those suffering from progressive fibrosis—aligning with evolving interstitial lung disease management strategies.

Blood Biomarkers Show Significant Associations

A major highlight of the study was the identification of pivotal correlations between routine hematologic markers and ailment characteristics:

  • Neutrophil count positively correlates with honeycombing on HRCT
    (r = 0.27)
  • Basophil count shows a link with bird-related antigen exposure
    (r = 0.26)

Although modest, these findings suggest that systemic inflammatory and immune responses may mirror structural lung impairment and exposure patterns.

Why This Matters?

These results position routine blood counts as accessible, low-cost adjunctive tools that could boost diagnostic confidence when interpreted alongside HRCT patterns and exposure history. In resource-limited settings, such biomarkers could be particularly valuable. However, researchers caution that these are exploratory findings and emphasize the requisition for large-scale studies to substantiate their diagnostic and prognostic utility.

Source:

Diagnostics (Basel)

Article:

Fibrotic Patterns and Diagnostic Correlates in Hypersensitivity Pneumonitis: Clinical, Radiologic, and Hematologic Insights

Authors:

Esma Sevil Akkurt et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: